Beyond the Capital Gap:
How Do We Develop an Operational Blueprint to Capitalise on UK Science?

This report examines three interconnected factors that influence whether early-stage technologies can successfully reach the market: venture building, access to real estate and critical equipment, and the availability of talent and skills. It therefore invites input from the government, academia, investors, developers and industry practitioners to help shape a more coordinated and effective national strategy.

We invite you to view the full report by completing the form below.

Recent reports from the House of Lords Science and Technology Committee, the House of Commons Science, Innovation and Technology Committee, and UKRI highlight similar concerns, pointing to a “national growth emergency” rooted in persistent structural challenges in commercialisation.

“Phase Two makes clear that unless we strengthen the infrastructure around talent, lab space and venture support, we will continue to lose ground to faster-moving global competitors. This is the moment for the UK to shift from analysis to co-ordinated action.”

Toby Reid, Executive Director – Pioneer Group

Authored by
Commissioned by

Fill out the form to download Phase Two

Published 27th March 2026

  • This field is for validation purposes and should be left unchanged.

View More Reports

Discover more with our full catalogue of reports.

Pioneer UK Life Science Start-up-Report - Full Catalogue

UK Life Science Start-up Reports

Pioneer UK Life Science Market Update Report - Full Catalogue

UK Life Science Market Update Reports

Industry Briefing Notes

Industry Briefing Notes

Industry Briefing Notes

Investment Showcase Reports

Life Science Industry Publications

Discover more about the industry with our library of life science industry publications, produced by the most reputable sources, including the UK Government, the UK BioIndustry Association and us at Pioneer Group.

  • Scaleup Institute Scaleup Annual Review 2020
  • BIA: The Science of Success: UK Biotech in 2020
  • UK Office For Life Sciences: Bioscience and Health Technology Sector Statistics 2019
  • Scottish Government: Life Sciences Innovation and Responding to Covid-19
  • Deloitte: 2020 Global Life Sciences Outlook
  • Many more